Looking for volunteers
PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND
NCT06144736 · Heinrich-Heine University, Duesseldorf · Updated 15 Sept 2025
- What is being tested
- Robot-assisted retroperitoneal lymph node dissection; Adjuvant therapy with one cycle of cisplatin, etoposide and bleomycin
- For
- Seminoma
- Kind of study
- Tests a treatment or device on volunteers. Phase 2.
- Who can join
- Ages 18 years to 99 years. About 60 people. The full rules are on the registry page.
- Where
- Germany
- When
- Starts or started 28 Aug 2023, ends 31 Aug 2029. Registered 22 Nov 2023.
- Results
- None posted yet.
In the researchers' words
PRIMETEST II is an interventional study involving low-volume metastatic seminoma. It explores a novel approach using robot-assisted primary retroperitoneal lymph node dissection, aiming to reduce long-term side effects and improve quality of life. By identifying factors predicting cancer recurrence, the study hopes to tailor treatments for better outcomes. The approach could potentially spare patients from chemotherapy induced long-term side effects while maintaining excellent survival rates, presenting a promising shift in testicular cancer care for this specific patient group.
Sites
- University Hospital of DuesseldorfDüsseldorf, Germany